EMD and colorectal cancer: In the study by Wang et al., [58] the use of Jacalin, ConA, RCA120, PHA-E, STA, LEL, WGA, DSL, and LCA lectins allowed to distinguish gastric and colorectal cancer patients according to their prognosis only by the glycans present on the EV surface.